不同磺脲类药物治疗初诊2型糖尿病患者的疗效
Effcacy of different sulfonylureas on newly diagnosed patients with type 2 diabetes
摘要
糖尿病已日渐成为威胁人类健康的慢性非传染性疾病之一。2011年9月14日国际糖尿病联盟（1DF）发布的新的糖尿病分布图显示，糖尿病流行情况仍在持续恶化，2011年全世界糖尿病患病人数达到了惊人的3．66亿，每年有460万人死于糖尿病。
出处
《药品评价》
CAS
2011年第23期25-30,39,共7页
Drug Evaluation
参考文献31
-
1Yang W,Lu J,Weng JJ,et al.Prevalence of Diabetes among Men and Women in China[l].N Engl J Med,2010,362:1090-1101.
-
2UK Prospective Diabetes Study (UKPDS) Group.United Kingdom Prospective Diabetes Study (UKPDS)13:Relative efficacy of randomly allocated diet,sulphonylurea,insulin,or metformin in patients with newly diagnosed noninsulin dependent diabetes followed for three years[J].BMJ,1995,310(6972):83-88.
-
3UK Prospective Diabetes Study (UKPDS) Group.Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)[J].Lancet,1998,352(9131):837-853.
-
4Riddle MC.More reasons to say goodbye to glyburide[J],J Clin Endocrinol Metab,2010,95(11):4867-4870.
-
5Al-Ozairi E,Sibal L,Home P.Counterpoint:A Diabetes Outcome Progression Trial (ADOPT):good for sulfonyiureas[J]? Diabetes Care,2007,30(6):1677-1680.
-
6Zeller M,Danchin N,Simon D,et al.Impact of type of preadmission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction.J Clin Endocrinol Metab,2010,95(11):4993-5002.
-
7Sadikot SM,Mogensen CE.Risk of coronary artery disease associated with initial sulphonylurea treatment of patients with type 2 diabetes:a matched case-control study[J].Diabetes Res Clin Pract,2008,82(3):391-395.
-
8Schernthaner G,Grimaldi A,Di Mario U,et al.GUIDE study:double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients[J].Eur J Clin Invest,2004,34(8):535-542.
-
9Gaede P,Lund-Andersen H,Parving HH,et al.Effect of a multifactorial intervention on mortality in type 2 diabetes[J].N Engl J Med,2008,358(6):580-591.
-
10Zoungas S,Chalmers J,Kengne AP,et al.The efficacy of lowering glycated haemoglobin with a gliclazide modified release-based intensive glucose lowering regimen in the ADVANCE trial[J].Diabetes Res Clin Pract,2010,89(2):126-133.
二级参考文献51
-
1刘国良,赵晓娟,都建,王秋月,张静,郑晓敏,曹翠平,任路平.糖适平治疗2型糖尿病的临床疗效观察[J].辽宁实用糖尿病杂志,2004,12(3):58-60. 被引量：10
-
2龚燕平,李春霖,田慧.格列喹酮治疗老年人2型糖尿病疗效观察[J].人民军医,2004,47(11):623-625. 被引量：6
-
3徐岩,李春霖.磺脲类降糖药物的临床应用及进展[J].中国药物应用与监测,2007,4(1):13-16. 被引量：7
-
4Carroll MF, Gutierrez A, Castro M, et al. Targeting postprandial hyperglycemia: a comparative study of insulinotropic agents in type 2 diabetes. J Clin Endominol Metab,2003 ,88 :5248-5254.
-
5Cozma LS, Luzio SD, Dunseath GJ, et al. Comparison of the effects of three insulinotropic drugs on plasma insulin levels after a standard meal. Diabetes Care ,2002,25 : 1472-1473.
-
6Chung M, Kourides I, Canovatchel W,et al. Pharmacokinetics and pharmacodynamics of extendedrelease glipizide GITS compared with immediaterelease glipizide in patients with type Ⅱ diabetes mellitus. J Clin Phamlaco1,2002 ,42 :651-657.
-
7Simonson DC, Kourides IA, Feinglos M, et al. Efficacy, safety, and doseresponse characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM. Diabetes Care, 1997,20:597-606.
-
8Berelowitz M, Fischette C, Cefalu W, et al. Comparative efficacy of a oncedaily controlledrelease formulation of glipizide and immediaterelease glipizide in patients with NIDDM. Diabetes Care, 1994,17 : 1460-1464.
-
9Peter P, Frank R, Nick G, et al. Sulfonylurea stimulation of in aulin secretion. Diabetes, 2002,51 ( Suppl 3): S368-S376.
-
10Garratt KN, Brady PA, Haasinger NL, et al. Sulfonylurea drugs increase early motality in patients with diabetes mellitus after direct angioplasty for acute myocardial infaction. J Am Cell Cardiol, 1999,33:119-124.
共引文献103
-
1吴红梅,袁启远,张雪梅.糖尿病肾病诊治进展[J].现代临床医学,2007,33(z2):177-180. 被引量：4
-
2范军,张治伦,张景.格列齐特口服导致反复发作严重低血糖一例[J].西藏医药,2014,35(3):33-34. 被引量：1
-
3郑刚,张承宗.2型糖尿病治疗模式的改变——从控制血糖到降低心血管疾病死亡率[J].中西医结合心脑血管病杂志,2005,3(4):351-354. 被引量：2
-
4邢小燕.改善β细胞功能,合理应用口服降糖药——2型糖尿病使用口服降糖药新理念及专家共识[J].实用糖尿病杂志,2005,1(3):5-7. 被引量：7
-
5格列齐特缓释片临床试验协作组.国产格列齐特缓释片治疗2型糖尿病的疗效及安全性[J].中华糖尿病杂志（1006-6187）,2005,13(5):375-377. 被引量：9
-
6顾明君,刘颖,刘春宏,方瑾,贺佳,刘志民.格列齐特缓释片治疗2型糖尿病的疗效及安全性[J].药学服务与研究,2006,6(1):38-41. 被引量：6
-
7吴坚,竺春玲,王黎霞,邵筱宏,邹大进.药物减重对肥胖型2型糖尿病的治疗作用[J].第二军医大学学报,2006,27(5):531-534.
-
8何颖.老年2型糖尿病两种初始治疗方法的比较[J].中国热带医学,2006,6(7):1241-1241.
-
9何颖,叶风.继发磺脲类药物失效时间探讨[J].海南医学院学报,2006,12(3):207-209.
-
10何颖.血塞通注射液治疗继发磺脲类药物失效30例[J].中国热带医学,2006,6(10):1849-1849.
-
1晚期肾细胞癌药物Afinitor欧洲获批[J].中国处方药,2009(9):57-57.
-
2孙保国,张宗显.一种新的鉴别蝎毒的方法[J].食品理化检验,1999(1):11-14. 被引量：1
-
3韩俊峰,侯君峰.盐酸乌拉地尔、氯沙坦联合治疗顽固性心衰25例疗效分析[J].中原医刊,2002,29(7):21-22.
-
4刘敏,黄绳武.胰岛素制剂的研究现状[J].中国药师,2006,9(2):174-176. 被引量：2
-
5王雪娜,肖拥军.新型GLP-1受体激动剂Lixisenatide的研究进展[J].中国现代医药杂志,2014,16(4):105-107. 被引量：2
-
6吴雅玲,王珍.胰岛素规律注射影响因素[J].临床护理杂志,2016,15(5):67-69. 被引量：2
-
7程立峰.尿频尿急，手术非首选[J].中国家庭医生,2013(16):22-22.
-
8程立峰,杨勇.尿频尿急，手术非首选[J].家庭药师,2014(8):18-19.
-
9徐洪玲,李诗良,赵振江,徐玉芳,李洪林.新型长效DPP-IV抑制剂的发现与设计[J].中国药理学通报,2015,31(B11):203-204.
-
10马李夏子,钱小亮,胡冬梅,白娟,陆杨,文爱东.2013年我院门诊口服降糖药应用分析[J].山西医药杂志,2015,44(12):1363-1365. 被引量：4
